These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 10527073

  • 1. Antitumor effect of vaccinia virus in glioma model.
    Timiryasova TM, Li J, Chen B, Chong D, Langridge WH, Gridley DS, Fodor I.
    Oncol Res; 1999; 11(3):133-44. PubMed ID: 10527073
    [Abstract] [Full Text] [Related]

  • 2. Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells.
    Timiryasova TM, Chen B, Fodor I.
    J Gene Med; 2001; 3(5):468-77. PubMed ID: 11601760
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model.
    Chen B, Timiryasova TM, Andres ML, Kajioka EH, Dutta-Roy R, Gridley DS, Fodor I.
    Cancer Gene Ther; 2000 Nov; 7(11):1437-47. PubMed ID: 11129286
    [Abstract] [Full Text] [Related]

  • 4. Vaccinia virus mediated p53 gene therapy for bladder cancer in an orthotopic murine model.
    Fodor I, Timiryasova T, Denes B, Yoshida J, Ruckle H, Lilly M.
    J Urol; 2005 Feb; 173(2):604-9. PubMed ID: 15643273
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Radiation enhances the anti-tumor effects of vaccinia-p53 gene therapy in glioma.
    Timiryasova TM, Gridley DS, Chen B, Andres ML, Dutta-Roy R, Miller G, Bayeta EJ, Fodor I.
    Technol Cancer Res Treat; 2003 Jun; 2(3):223-35. PubMed ID: 12779353
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B, Gridley DS, Fodor N, Takátsy Z, Timiryasova TM, Fodor I.
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antitumor effect of IL-2, p53, and bax gene transfer in C6 glioma cells.
    Haghighat P, Timiryasova TM, Chen B, Kajioka EH, Gridley DS, Fodor I.
    Anticancer Res; 2000 Jul; 20(3A):1337-42. PubMed ID: 10928041
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence.
    Reading PC, Khanna A, Smith GL.
    Virology; 2002 Jan 20; 292(2):285-98. PubMed ID: 11878931
    [Abstract] [Full Text] [Related]

  • 17. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
    Geoerger B, van Beusechem VW, Opolon P, Morizet J, Laudani L, Lecluse Y, Barrois M, Idema S, Grill J, Gerritsen WR, Vassal G.
    J Gene Med; 2005 May 20; 7(5):584-94. PubMed ID: 15651070
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas.
    Benítez JA, Arregui L, Vergara P, Segovia J.
    Cancer Gene Ther; 2007 Oct 20; 14(10):836-46. PubMed ID: 17599090
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.